MustGrow Biologics (CSE: MGRO) has initiated a South American strategy for the registration of TerraMG for its use in several crop groups a a bio-pesticide. The announcement follows the continued registration efforts with the US EPA and the Canadian PMRA.
TerraMG is MustGrow’s flagship product, which is derived from mustard seed to create a liquid pre-plant bio-pesticide formulation. The product has been tested meticulously, and is proved to control soil-borne pests and diseases that include botrytis, pythium, fusarium, rhizoctonia, and nematodes, among others. The formulation is intended as a pre-planting treatment to rid the soil of pests and disease in high value crops that include fruits, vegetables, turf, and ornamentals.
MustGrow’s South American strategy will begin in Colombia, where the company is pursing registration for TerraMG as a bio-pesticide in crops that include coffee, oil palm, and various floriculture. The company will also be conducting a proof-of-concept on Panama Disease, which is a disease that threatens the global banana supply.
Panama Disease is caused by Fusarium, a disease which TerraMG has demonstrated 100% control of. The disease is so damaging that Colombia has declared a national state of emergency on the situation, and has gone as far as destroying hundreds of acres of infected crop to prevent the spread of the disease. The country is going to extensive efforts to reduce the spread of the disease due to bananas being the nation’s third largest agricultural export. The disease was responsible for the 1950’s demise of the Gros Michel variety of banana, which was replaced by the Cavendish variety. However, due to a lack of genetic diversity, the Cavendish is now faced with the same threat as its predecessor.
The company is currently waiting on final approval for importation from the Colombian government for TerraMG. The company will first conduct laboratory testing on the liquid formulation prior to conducting field tests to analyze the efficacy of the product against numerous soil-borne pests and disease found in the South American region.
MustGrow Biologics last traded at $0.33 on the CSE.
FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.